Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
COSCIENS Biopharma Inc. (CSCIF) had Operating Cash Flow per Share of $-0.59 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.89M |
|
$10.76M |
|
$1.09M |
|
$0.79M |
|
$2.62M |
|
$-0.73M |
|
$0.55M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$10.76M |
|
$-0.18M |
|
$-0.73M |
|
$-0.39M |
|
3.14M |
|
3.71M |
|
$3.42 |
|
$2.90 |
|
| Balance Sheet Financials | |
$9.39M |
|
$9.24M |
|
$9.45M |
|
$18.84M |
|
$1.69M |
|
-- |
|
$1.84M |
|
$3.52M |
|
$15.32M |
|
$15.32M |
|
$15.32M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-2.18M |
|
$-0.02M |
|
$-0.08M |
|
$7.31M |
|
$5.00M |
|
$-2.30M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
42.00% |
|
-38.67% |
|
-38.67% |
|
-- |
|
-9.69% |
|
569.76% |
|
$-2.17M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.00 |
|
0.95 |
|
95.05 |
|
-1.19% |
|
-1.19% |
|
-0.97% |
|
-1.19% |
|
$4.81 |
|
$-0.58 |
|
|
Operating Cash Flow per Share |
$-0.59 |